Cargando…

Validation of Geant4 fragmentation for Heavy Ion Therapy

$^{12}$C ion therapy has had growing interest in recent years for its excellent dose conformity. However at therapeutic energies, which can be as high as 400 MeV/u, carbon ions produce secondary fragments. For an incident 400 MeV/u 12C ion beam, $\sim 70 \%$ of the beam will undergo fragmentation be...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolst, David, Cirrone, Giuseppe A P, Cuttone, Giacomo, Folger, Gunter, Incerti, Sebastien, Ivanchenko, Vladimir, Koi, Tatsumi, Mancusi, Davide, Pandola, Luciano, Romano, Francesco, Rosenfeld, Anatoly B, Guatelli, Susanna
Lenguaje:eng
Publicado: 2017
Materias:
Acceso en línea:https://dx.doi.org/10.1016/j.nima.2017.06.046
http://cds.cern.ch/record/2316019
_version_ 1780958188920635392
author Bolst, David
Cirrone, Giuseppe A P
Cuttone, Giacomo
Folger, Gunter
Incerti, Sebastien
Ivanchenko, Vladimir
Koi, Tatsumi
Mancusi, Davide
Pandola, Luciano
Romano, Francesco
Rosenfeld, Anatoly B
Guatelli, Susanna
author_facet Bolst, David
Cirrone, Giuseppe A P
Cuttone, Giacomo
Folger, Gunter
Incerti, Sebastien
Ivanchenko, Vladimir
Koi, Tatsumi
Mancusi, Davide
Pandola, Luciano
Romano, Francesco
Rosenfeld, Anatoly B
Guatelli, Susanna
author_sort Bolst, David
collection CERN
description $^{12}$C ion therapy has had growing interest in recent years for its excellent dose conformity. However at therapeutic energies, which can be as high as 400 MeV/u, carbon ions produce secondary fragments. For an incident 400 MeV/u 12C ion beam, $\sim 70 \%$ of the beam will undergo fragmentation before the Bragg Peak. The dosimetric and radiobiological impact of these fragments must be accurately characterised, as it can result in increasing the risk of secondary cancer for the patient as well as altering the relative biological effectiveness. This work investigates the accuracy of three different nuclear fragmentation models available in the Monte Carlo Toolkit Geant4, the Binary Intranuclear Cascade (BIC), the Quantum Molecular Dynamics (QMD) and the Liege Intranuclear Cascade (INCL++). The models were benchmarked against experimental data for a pristine 400 MeV/u $^{12}$C beam incident upon a water phantom, including fragment yield, angular and energy distribution. For fragment yields the three alternative models agreed between $\sim 5$ and $\sim 35 \%$ with experimental measurements, the QMD using the “Frag” option gave the best agreement for lighter fragments but had reduced agreement for larger fragments. For angular distributions INCL++ was seen to provide the best agreement among the models for all elements with the exception of Hydrogen, while BIC and QMD was seen to produce broader distributions compared to experiment. BIC and QMD performed similar to one another for kinetic energy distributions while INCL++ suffered from producing lower energy distributions compared to the other models and experiment.
id oai-inspirehep.net-1640824
institution Organización Europea para la Investigación Nuclear
language eng
publishDate 2017
record_format invenio
spelling oai-inspirehep.net-16408242019-09-30T06:29:59Zdoi:10.1016/j.nima.2017.06.046http://cds.cern.ch/record/2316019engBolst, DavidCirrone, Giuseppe A PCuttone, GiacomoFolger, GunterIncerti, SebastienIvanchenko, VladimirKoi, TatsumiMancusi, DavidePandola, LucianoRomano, FrancescoRosenfeld, Anatoly BGuatelli, SusannaValidation of Geant4 fragmentation for Heavy Ion TherapyParticle Physics - Phenomenology$^{12}$C ion therapy has had growing interest in recent years for its excellent dose conformity. However at therapeutic energies, which can be as high as 400 MeV/u, carbon ions produce secondary fragments. For an incident 400 MeV/u 12C ion beam, $\sim 70 \%$ of the beam will undergo fragmentation before the Bragg Peak. The dosimetric and radiobiological impact of these fragments must be accurately characterised, as it can result in increasing the risk of secondary cancer for the patient as well as altering the relative biological effectiveness. This work investigates the accuracy of three different nuclear fragmentation models available in the Monte Carlo Toolkit Geant4, the Binary Intranuclear Cascade (BIC), the Quantum Molecular Dynamics (QMD) and the Liege Intranuclear Cascade (INCL++). The models were benchmarked against experimental data for a pristine 400 MeV/u $^{12}$C beam incident upon a water phantom, including fragment yield, angular and energy distribution. For fragment yields the three alternative models agreed between $\sim 5$ and $\sim 35 \%$ with experimental measurements, the QMD using the “Frag” option gave the best agreement for lighter fragments but had reduced agreement for larger fragments. For angular distributions INCL++ was seen to provide the best agreement among the models for all elements with the exception of Hydrogen, while BIC and QMD was seen to produce broader distributions compared to experiment. BIC and QMD performed similar to one another for kinetic energy distributions while INCL++ suffered from producing lower energy distributions compared to the other models and experiment.oai:inspirehep.net:16408242017
spellingShingle Particle Physics - Phenomenology
Bolst, David
Cirrone, Giuseppe A P
Cuttone, Giacomo
Folger, Gunter
Incerti, Sebastien
Ivanchenko, Vladimir
Koi, Tatsumi
Mancusi, Davide
Pandola, Luciano
Romano, Francesco
Rosenfeld, Anatoly B
Guatelli, Susanna
Validation of Geant4 fragmentation for Heavy Ion Therapy
title Validation of Geant4 fragmentation for Heavy Ion Therapy
title_full Validation of Geant4 fragmentation for Heavy Ion Therapy
title_fullStr Validation of Geant4 fragmentation for Heavy Ion Therapy
title_full_unstemmed Validation of Geant4 fragmentation for Heavy Ion Therapy
title_short Validation of Geant4 fragmentation for Heavy Ion Therapy
title_sort validation of geant4 fragmentation for heavy ion therapy
topic Particle Physics - Phenomenology
url https://dx.doi.org/10.1016/j.nima.2017.06.046
http://cds.cern.ch/record/2316019
work_keys_str_mv AT bolstdavid validationofgeant4fragmentationforheavyiontherapy
AT cirronegiuseppeap validationofgeant4fragmentationforheavyiontherapy
AT cuttonegiacomo validationofgeant4fragmentationforheavyiontherapy
AT folgergunter validationofgeant4fragmentationforheavyiontherapy
AT incertisebastien validationofgeant4fragmentationforheavyiontherapy
AT ivanchenkovladimir validationofgeant4fragmentationforheavyiontherapy
AT koitatsumi validationofgeant4fragmentationforheavyiontherapy
AT mancusidavide validationofgeant4fragmentationforheavyiontherapy
AT pandolaluciano validationofgeant4fragmentationforheavyiontherapy
AT romanofrancesco validationofgeant4fragmentationforheavyiontherapy
AT rosenfeldanatolyb validationofgeant4fragmentationforheavyiontherapy
AT guatellisusanna validationofgeant4fragmentationforheavyiontherapy